Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATN-103 in Japanese subjects with active rheumatoid arthritis
NCT01007175Phase 2Completed
- Sponsor
- Sanofi
- Start
- Nov 2009
- Primary completion
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes, Nanobodies (VHH)
- Countries
- 1
01
Overview
A Phase 2 trial of ozoralizumab in rheumatoid arthritis (RA), sponsored by Sanofi. Started Nov 2009; status: completed.
02
Drugs
ozoralizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01007175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01007175.